LSE:AZN
LSE:AZNPharmaceuticals

Taking Stock of AstraZeneca (LSE:AZN): Is Its 31% One-Year Return Now Fully Valued?

AstraZeneca (LSE:AZN) has quietly ground out solid gains over the past year, and today’s move is less about a flashy headline and more about how that trend stacks up against its fundamentals. See our latest analysis for AstraZeneca. The latest dip in AstraZeneca’s £135.92 share price comes after a strong run, with a 90 day share price return of 7.45% contributing to a 1 year total shareholder return of 31.08%, suggesting momentum is still broadly constructive. If AstraZeneca’s steady progress...